home / stock / sbfm / sbfm news


SBFM News and Press, Sunshine Biopharma Inc. From 04/05/22

Stock Information

Company Name: Sunshine Biopharma Inc.
Stock Symbol: SBFM
Market: OTC
Website: sunshinebiopharma.com

Menu

SBFM SBFM Quote SBFM Short SBFM News SBFM Articles SBFM Message Board
Get SBFM Alerts

News, Short Squeeze, Breakout and More Instantly...

SBFM - Sunshine Biopharma, Nano-X top healthcare gainers; IMARA, GBS lead losers' pack

Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...

SBFM - Trading Penny Stocks, April 5th, SBFM and TWTR Explode

Buying Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks here, there is a lot for investors to consider. Yesterday, we got big news when billionaire Elon Musk announced that he had over $3 billion or a 9.2% stake in TWTR stock. This caused ...

SBFM - Best Penny Stocks Today: Why SBFM Stock Is Moving 175%+

Top Penny Stocks Today: Here’s Why Sunshine Biopharma Stock Is Moving Traders love finding the top penny stocks to buy as early as possible. That’s especially true if the stocks are making big moves. In the stock market today , you have plenty to choose from. The first...

SBFM - Sunshine Biopharma soars on anticancer effect of mRNA molecules

Sunshine Biopharma (NASDAQ:SBFM), a biotech focused on oncology, has added ~147% in the pre-market Tuesday after the company announced that two of its newly designed mRNA molecules were effective against cancer cells. The cells grown in culture included multidrug-resistant breast ca...

SBFM - BTU, NNOX and CEIX among pre market gainers

Sunshine Biopharma (SBFM) +119% newly designed mRNA molecules prove effective against multidrug resistant cancer cells. System1 (SST) +26%. Recon Technology (RCON) +23%. Aterian (ATER) +13%. Guardforce AI (GFAI) +12% on expanding applications of robotics solutions. Arcus Biosci...

SBFM - Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

MONTREAL, April 05, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that two of its newly designed...

SBFM - PAGS, BEKE and ARDX among pre market gainers

StoneCo (STNE) +29% on Q4 results. Kidpik (PIK) +22%. Sunshine Biopharma (SBFM) +16%. Yumanity Therapeutics (YMTX) +12%. On Holding (ONON) +9% on Q4 results. Hycroft Mining Holding (HYMC) +9%. PagSeguro Digital (PAGS) +8%. Houston American Energy (HUSA) +8%. Zhihu (ZH) +8%...

SBFM - Zai Lab, 111 top healthcare gainers; Talis Biomedical, Incannex lead losers' pack

Gainers: Zai Lab (NASDAQ:ZLAB) +27%. 111 (NASDAQ:YI) +26%. LianBio (NASDAQ:LIAN) +22%. BeiGene BGNE +20%. Palisade Bio PALI +10%. Losers: Talis Biomedical (NASDAQ:TLIS) -42%. Incannex Healthcare (NASDAQ:IXHL) -32%. NLS Pharmaceutics NLSP&...

SBFM - Sunshine Biopharma rebounds after closing $8M private placement

Following three straight sessions of losses, the shares of development-stage biotech, Sunshine Biopharma (SBFM +30.4%), have rebounded in the morning hours Tuesday after the company announced it closed the previously announced private placement. Last week, the company announced it entered int...

SBFM - Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ: SBFM)

NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ:SBFM) About Sunshine Biopharma, Inc. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative ...

Previous 10 Next 10